You are currently viewing ASHP Advantage activities. Click here to view full catalog of ASHP offerings.

Advantage Catalog

Found 32
Sort by
Online Program
Member Free
Non-Member Free

Addressing Barriers to Biosimilar Integration in Cancer Care

This 1.5-hour online educational activity presents clinical information on the use of biosimilars for supportive and therapeutic cancer care, discusses the barriers to biosimilar adoption, and presents strategies to overcome these barriers.
clinical pharmacy practice oncology
Online Program
Member Free
Non-Member Free

An Interprofessional Approach to Improving Medication Administration for Optimal Vessel Health and Preservation

This 1.5-hour online interprofessional educational activity reviews the issues associated with optimal medication administration to prioritize vessel health and preservation.
clinical pharmacy practice acute/critical care
Online Program
Member Free
Non-Member Free

Ask the Experts: Addressing Challenges Related to Reversal of Neuromuscular Blockade

This 1.0-hour online educational activity focuses on challenges related to reversal of neuromuscular blockade, including special patient populations, postoperative nausea and vomiting, and rapid sequence intubation. Use of a team-based practice model in the perioperative space is also discussed.
acute/critical care leadership/management
Online Program
Member Free
Non-Member Free

Ask the Experts: Optimizing the Use and Management of Immune Checkpoint Inhibitors

This 1-hour online educational activity explores the growing role of immune checkpoint inhibition as standard management for less common malignancies and new updated indications. The current literature centered on identifying clinically relevant predictive biomarkers will also be reviewed.
oncology pharmacotherapy
Online Program
Member Free
Non-Member Free

Best practice update on Clostridium difficile Infection (CDI): Focus on Prevention, Treatment and Recurrence

This 1.0-hour online educational activity will provide a state-of-the art update on best practice treatment of Clostridium difficile infection (CDI) with a focus on guideline updates, antibiotic stewardship strategies, and sustained clinical response.
infectious diseases clinical pharmacy practice
Online Program
Member Free
Non-Member Free

Cardio-renal Complications of Type 2 Diabetes: Focus on Heart Failure

This online educational activity will review the causative role of type 2 diabetes mellitus in the development of renal disease and heart failure. This activity is not eligible for CE.
diabetes/endocrine
Online Program
Member Free
Non-Member Free

Clinical Case Dialogue: Managing Serious Gram-negative Infections in the Hospital

In this 1.0-hour online educational activity, case scenarios are used to illustrate challenges in the treatment of Gram-negative bacterial infections in hospitalized patients. Strategies for advancing antimicrobial stewardship in the hospital are also discussed.
infectious diseases acute/critical care
Online Program
Member Free
Non-Member Free

Contemporary Approaches to the Management of Hemophilia A: An Individualized Approach to Care

This activity was planned to meet the educational needs of pharmacists who care for patients with hemophilia A.
ambulatory care clinical pharmacy practice acute/critical care
Online Program
Member Free
Non-Member Free

Current and Emerging Approaches to the Use of Probiotics: Clinical Case Studies

In this 1-hour online educational activity, the faculty use patient case scenarios to illustrate best practices in the selection and use of probiotics for disease management, taking into account currently available evidence and real-life clinical situations in hospital and ambulatory care settings.
ambulatory care acute/critical care nutrition/tpn
Online Program
Member Free
Non-Member Free

Evolving Role of Immunotherapy in Cancer Treatment

This 1.5-hour online educational activity will explore the evolving role of immunotherapies in treating patients with cancer. Patient cases will be utilized to highlight therapy selection as well as common adverse effects and toxicity management strategies.
oncology pharmacotherapy